miR145, an inhibitor of the embryonic stem cell program, was found to counteract the effects of mutant KRAS by suppressing malignant growth and promoting the differentiation of mutant KRAS colon cancer cells [72]. This evidence concerns the gene KRAS and malignant colon neoplasm.